These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17671718)
21. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494 [TBL] [Abstract][Full Text] [Related]
22. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146 [TBL] [Abstract][Full Text] [Related]
23. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pham NA; Tsao MS; Cao P; Hedley DW Pancreas; 2007 Oct; 35(3):e16-26. PubMed ID: 17895832 [TBL] [Abstract][Full Text] [Related]
24. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811 [TBL] [Abstract][Full Text] [Related]
25. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas. Yang D; Shi J; Fu H; Wei Z; Xu J; Hu Z; Zhang Y; Yan R; Cai Q Tumour Biol; 2016 Sep; 37(9):12315-12327. PubMed ID: 27289231 [TBL] [Abstract][Full Text] [Related]
26. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924 [TBL] [Abstract][Full Text] [Related]
28. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer. Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Wang TX; You L; Shu H Arch Med Res; 2014 Jan; 45(1):15-20. PubMed ID: 24316112 [TBL] [Abstract][Full Text] [Related]
29. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. Jiang C; Yi XP; Shen H; Li YX World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919 [TBL] [Abstract][Full Text] [Related]
30. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. Khanna A; Mahalingam K; Chakrabarti D; Periyasamy G Cell Mol Biol Lett; 2011 Mar; 16(1):101-13. PubMed ID: 21225469 [TBL] [Abstract][Full Text] [Related]
31. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235 [TBL] [Abstract][Full Text] [Related]
32. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro. Xiong GS; Sun HL; Wu SM; Mo JZ J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735 [TBL] [Abstract][Full Text] [Related]
33. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine. Cao LP; Song JL; Yi XP; Li YX Oncol Rep; 2013 Apr; 29(4):1659-65. PubMed ID: 23354694 [TBL] [Abstract][Full Text] [Related]
34. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602 [TBL] [Abstract][Full Text] [Related]
35. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway. Wu Y; Xu W; Yang Y; Zhang Z Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560 [TBL] [Abstract][Full Text] [Related]
36. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. Kato H; Seto K; Kobayashi N; Yoshinaga K; Meyer T; Takei M Life Sci; 2011 Oct; 89(17-18):603-8. PubMed ID: 21839751 [TBL] [Abstract][Full Text] [Related]
37. DNA-PKcs is important for Akt activation and gemcitabine resistance in PANC-1 pancreatic cancer cells. Hu H; Gu Y; Qian Y; Hu B; Zhu C; Wang G; Li J Biochem Biophys Res Commun; 2014 Sep; 452(1):106-11. PubMed ID: 25152407 [TBL] [Abstract][Full Text] [Related]
38. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
39. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA]. Kong R; Sun B; Wang SJ; Pan SH; Wang G; Chen H; Xue DB; Jiang HC Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):128-33. PubMed ID: 20302733 [TBL] [Abstract][Full Text] [Related]
40. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]